Literature DB >> 20831864

Serum osteocalcin is related to abdominal obesity in Korean obese and overweight men.

Sang-Hwan Kim1, Ji-Won Lee, Jee-Aee Im, Hee-Jin Hwang.   

Abstract

BACKGROUND: Growing evidence suggests a link between body composition and serum osteocalcin. Here we examined such an association between serum osteocalcin and body composition in Korean obese men.
METHODS: Eighty-six men, aged 20 to 76 years, who visited the obesity clinic at the Division of Family Medicine, Severance hospital, Seoul, Korea were recruited for this study. Abdominal fat computed tomography (CT) scans were performed to measure the visceral fat area (VFA) and subcutaneous fat area (SFA).
RESULTS: Serum osteocalcin levels were negatively correlated with age, VFA, and VFA/SFA ratio. In addition, serum osteocalcin levels were significantly decreased in obese and overweight subjects with visceral obesity (12.7±3.2) compared to those without visceral obesity (18.6±4.9). Multiple regression analysis showed that serum osteocalcin levels were associated with VFA in obese and overweight men after adjustment for age, insulin resistance, current smoking, alcohol consumption and adiposity indices.
CONCLUSION: Osteocalcin was inversely related to visceral obesity in Korean obese and overweight men. These results suggest cross-talk between bone and adipose tissue.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20831864     DOI: 10.1016/j.cca.2010.08.046

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  14 in total

1.  Osteocalcin and its association with testosterone in patients with metabolic diseases.

Authors:  G Strapazzon; A Garolla; U Carraro; C Foresta
Journal:  Osteoporos Int       Date:  2012-09-29       Impact factor: 4.507

2.  Total osteocalcin in serum predicts testosterone level in male type 2 diabetes mellitus.

Authors:  Ran Cui; Bin Su; Chunjun Sheng; Xiaoyun Cheng; Peng Yang; Le Bu; Hong Li; Jiying Wang; Hui Sheng; Shen Qu
Journal:  Int J Clin Exp Med       Date:  2014-04-15

Review 3.  Association between serum osteocalcin and body mass index: a systematic review and meta-analysis.

Authors:  Hamed Kord-Varkaneh; Kurosh Djafarian; Masoud Khorshidi; Sakineh Shab-Bidar
Journal:  Endocrine       Date:  2017-08-18       Impact factor: 3.633

4.  Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice.

Authors:  Mathieu Ferron; Marc D McKee; Robert L Levine; Patricia Ducy; Gérard Karsenty
Journal:  Bone       Date:  2011-04-29       Impact factor: 4.398

5.  Association between osteocalcin and glucose metabolism: a meta-analysis.

Authors:  D-M Liu; X-Z Guo; H-J Tong; B Tao; L-H Sun; H-Y Zhao; G Ning; J-M Liu
Journal:  Osteoporos Int       Date:  2015-06-19       Impact factor: 4.507

6.  Significant association between body composition phenotypes and the osteocalcin genomic region in normative human population.

Authors:  Michael Korostishevsky; Ida Malkin; Svetlana Trofimov; Yufang Pei; Hong-Wen Deng; Gregory Livshits
Journal:  Bone       Date:  2012-07-24       Impact factor: 4.398

7.  Autophagic dysfunction is improved by intermittent administration of osteocalcin in obese mice.

Authors:  B Zhou; H Li; J Liu; L Xu; Q Guo; W Zang; H Sun; S Wu
Journal:  Int J Obes (Lond)       Date:  2016-01-07       Impact factor: 5.095

8.  Osteocalcin increase after bariatric surgery predicts androgen recovery in hypogonadal obese males.

Authors:  J Samavat; E Facchiano; G Cantini; A Di Franco; G Alpigiano; G Poli; G Seghieri; M Lucchese; G Forti; M Luconi
Journal:  Int J Obes (Lond)       Date:  2013-12-05       Impact factor: 5.095

9.  Association between Osteocalcin, Metabolic Syndrome, and Cardiovascular Risk Factors: Role of Total and Undercarboxylated Osteocalcin in Patients with Type 2 Diabetes.

Authors:  Assim A Alfadda; Afshan Masood; Shaffi Ahamed Shaik; Hafedh Dekhil; Michael Goran
Journal:  Int J Endocrinol       Date:  2013-04-09       Impact factor: 3.257

10.  Serum under-carboxylated osteocalcin levels in women with polycystic ovary syndrome: weight-dependent relationships with endocrine and metabolic traits.

Authors:  Carmen E Pepene
Journal:  J Ovarian Res       Date:  2013-01-22       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.